Genentec, OSI Pharma to pay $67M to resolve Tarceva false claims
June 07, 2016 at 16:24 PM EDT
Allen Cone SAN FRANCISCO, D.C., June 7 (UPI) -- Pharmaceutical firms Genentech Inc. and OSI Pharmaceuticals LLC will pay $67 million to settle False Claims Act allegations involving cancer drug Tarceva.
